01.03.2016
- British drugmaker GlaxoSmithKline is said to have launched a search for a new CEO to replace Andrew Witty, who is now widely expected to step down at the latest by the end of 2017...
05.02.2016
- Glaxo SmithKline CEO Andrew Witty has become the first pharmaceutical or chemical company executive to come out in favor of the UK remaining in the EU, although business leaders in...
